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The Association Between Constipation and Lower
Urinary Tract Symptoms in Parous Middle-Aged Women:
A Prospective Cohort Study
Nour Alhababi, MSc,1 Maria Christine Magnus, PhD,1–3 Marcus John Drake, MA (Cantab), BA (Oxon), DM,4
Abigail Fraser, PhD,1,3 and Carol Joinson, PhD1
Abstract
Objective: To examine the prospective association between constipation and risk of developing lower urinary
tract symptoms (LUTS) in parous middle-aged women.
Materials and Methods: The study uses data from 3,729 women from the Avon Longitudinal Study of Parents and
Children who provided self-reports of medication intake for constipation at two time points (Baseline): 2001–2003
and 2003–2005. Women with LUTS at baseline were excluded. After 10 years of follow-up, women provided self-
reports of LUTS using an adapted version of the International Consultation on Incontinence Questionnaire on
Female LUTS. LUTS were categorized according to International Continence Society definitions as stress urinary
incontinence (UI), urgency UI, mixed UI, nocturia, increased daytime frequency, urgency, hesitancy, and inter-
mittency. LUTS were considered present if symptoms were reported to occur at least ‘‘sometimes’’ for all subtypes,
except for increased daytime frequency (‡9 times) and nocturia (‡2 times nightly).
Results: At follow-up, the prevalence of any LUTS was 40%. Women (mean age 43.3 years, standard deviation
0.5), who took medication for constipation at either time point had increased risks of urgency (adjusted relative
risks [RRs] = 1.35; 95% confidence interval [CI] 1.04–1.95) and hesitancy (adjusted RR = 1.72; 95% CI 1.04–
3.01) compared with women who reported not using medication for constipation at either time point. The risk of
urgency (adjusted RR = 1.94; 95% CI 1.15–3.29) and hesitancy (adjusted RR = 1.78; 95% CI 1.03–4.19) was
greater for women who reported taking medication for constipation at both time points. There was no evidence
that constipation was associated with stress UI, urgency UI, mixed UI, nocturia, increased daytime frequency,
and intermittency.
Conclusion: Constipation is prospectively associated with an increased risk of urgency and hesitancy among
parous middle-aged women. If further research finds evidence that this association is causal, this implies that
women should seek treatment to alleviate constipation to reduce their consequent risk of developing these LUTS.
Keywords: LUTS, constipation, urinary incontinence, women’s health, ALSPAC
Introduction
The International Continence Society (ICS) groupslower urinary tract symptoms (LUTS) into storage, void-
ing, and postmicturition symptoms.1 Stress urinary incontinence
(UI) is the most common subtype of LUTS (prevalence ranging
10%–39%), followed by mixed UI (prevalence ranging 7.5%–
25%), and then urgency UI (prevalence ranging 1%–7%).2
LUTS in women have been linked to lower quality of life
due to interference with daily living,3,4 and are associated
with a substantial psychological and economic burden.5
Established risk factors for LUTS include parity, delivery
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mode, older age, obesity, and hysterectomy.2,6,7 It has also
been suggested that constipation could increase the risk of
LUTS in women.8,9 This is because the urinary and bowel
tracts are interrelated structures and their common embryology,
overlapping innervation, and anatomical proximity could mean
that dysfunction in the bowel may affect the bladder.8,9 Con-
stipation is common and is estimated to affect 12%–32%
of middle-aged women.9 The National Institute for Health and
Care Excellence guidelines state that constipation and LUTS
often co-occur and recommend screening for constipation in
women while assessing and treating LUTS.10 The temporal
relationship between constipation and LUTS is, however, un-
clear because previous studies are mostly cross-sectional.
Other limitations of conducted studies include modest sample
sizes, limited adjustment for potentially important confound-
ers, such as physical activity and hysterectomy,11–15 and recall
bias when participants report constipation retrospectively.
It is important to examine whether constipation is pro-
spectively associated with developing LUTS as this could
have important implications for prevention of LUTS. The
aim of our study is to examine the prospective association
between constipation and risk of LUTS in a large cohort of
parous middle-aged women with a 10-year follow-up period.
Materials and Methods
Our study includes women participating in the Avon
Longitudinal Study of Parents and Children (ALSPAC).16,17
ALSPAC is a prospective population-based birth cohort
study, which recruited 14,541 pregnant women residing in
the former Avon Health Authority in England, with an esti-
mated date of delivery between April 1991 and December
1992. Detailed information can be found at the cohort website
(www.bristol.ac.uk/alspac), including a fully searchable data
dictionary (www.bristol.ac.uk/alspac/researchers/our-data/).
Ethics approval for the study was obtained from the ALSPAC
Ethics and Law Committee and the Local Research Ethics
Committees. The relevant Ethics Committee or Institutional
Review Board provided (or waived) approval.
We defined the baseline of the current study between 2001
and 2005, at which time we excluded prevalent cases of
LUTS and classified women according to whether they were
taking medication to treat constipation or not. A total of 3,922
women had information on constipation and had not expe-
rienced LUTS at baseline (Fig. 1). Of these women, 3,729
had information on LUTS after 10 years of follow-up and
were included in the current study (2011–2012) (Fig. 1).
Constipation
Use of medication for constipation was self-reported in
questionnaires at two time points (between 2001–2003 and
2003–2005). Women were asked to indicate whether they had
‘‘used any medicines (pills, syrups, inhalers, drops, sprays,
suppositories, pessaries, ointments etc., including homeo-
pathic and herbal remedies) in the last 12 months for con-
stipation.’’ Women indicated ‘‘yes’’ in response to this
question by checking a box, whereas all women who did not
respond ‘‘yes’’ were assumed to not have used any medi-
cines for constipation in the past 12 months. We catego-
rized the responses to using medications for constipation
during the two time points as: none, yes at one of the two
time points, and yes at both time points.
To increase statistical power, we repeated the analysis by
collapsing the constipation variable into two categories in-
stead of three: women who reported ‘‘no constipation’’ and
women who reported ‘‘taking medication for constipation at
any time point.’’
Lower urinary tract symptoms
We chose to look at both storage and voiding symptoms due
to their burden and impact on women’s quality of life.5,18
Women completed a range of questions on LUTS that are drawn
from the validated Bristol Female LUTS (BFLUTS) question-
naire at baseline (2002–2004).19 Women who reported LUTS
symptoms (including stress UI, mixed UI, urgency UI, urgency,
nocturia, increased daytime frequency, hesitancy and intermit-
tency) at baseline were excluded. After 10 years of follow-up,
women completed the International Consultation on Incon-
tinence Questionnaire on Female LUTS (ICIQ-FLUTS).20
The ICIQ-FLUTS modular questionnaire used after 10 years
of follow-up was adapted from the BFLUTS questionnaire. It
includes the same questions as the BFLUTS, in addition to
questions capturing women’s ratings of whether, and to what
degree, they rated the LUTS as bothersome. Based on the ICS
definition, we categorized the responses according to differ-
ent types of LUTS, including stress UI, urgency UI, mixed
UI, urgency, nocturia, increased daytime frequency, hesi-
tancy, and intermittency. A high percentage of women (49%
of women) reported waking up once at night to urinate
compared with waking up twice at night (7% of women).
Therefore, we additionally examined women’s ratings of
how bothersome they found waking up once a night to uri-
nate versus twice a night. Waking once a night to urinate was
generally not considered bothersome, therefore, we decided
to define nocturia as waking up to urinate two or more times
per night.21 We also examined any type of LUTS which
includes any storage or voiding symptom.
Box 1 lists the LUTS related questions included in the
BFLUTS and ICIQ-questionnaires, which were used to identify
women with LUTS at baseline and at follow-up after 10 years.
LUTS were considered present if symptoms were reported
to occur at least ‘‘sometimes’’ for all subtypes, except for in-
creased daytime frequency (‡9 times) and nocturia (‡2 times
nightly). We were unable to include unexplained UI, enuresis,
and straining to void because there were very small numbers of
women reporting experiencing these LUTS, preventing any
meaningful analysis. The LUTS questionnaires did not ask
about other voiding symptoms, including slow stream, spraying
of urinary stream, and terminal dribble.
Other variables
Potential confounders that could influence both con-
stipation and LUTS were identified by a detailed search of
the literature and clinical knowledge. Confounders included
age (self-reported at recruitment), educational qualifications
categorized as university degree versus no degree (Certificate
of Secondary Education, Vocational, Ordinary level, Advanced
level), occupational social class (1991 British Office of Popu-
lation and Census Statistics—dichotomized into manual and
nonmanual), body mass index (BMI: calculated from self-
reported height and weight at baseline), parity (self-reported by
women at recruitment and categorized into 1, 2, 3, or more
births), hysterectomy (self-reported by women at baseline and
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categorized into yes/no), and physical activity (self-reported at
baseline and translated into total metabolic equivalents [MET]
minutes per week and categorized into five categories: 0, 0.1–
17.2, 17.3–29.2, 29.3–43.2, and >43.2 MET hours/week).
Characteristics of women may have changed during the
follow-up period between exposure and outcome measures.
Therefore, we re-ran the complete case analysis with updated
variables, including age, BMI (measured at the time of outcome
assessment), parity, and hysterectomy (measured 2 years before
outcome assessment). We were unable to account for any po-
tential changes in physical activity, education, or social class
after baseline.
Statistical analyses
We used log-binomial multivariable regression to esti-
mate the association between constipation (none/at one time
point/at both time points) and subtypes of LUTS, reporting
relative risks (RRs) and 95% confidence intervals (CIs).
We used multiple imputation to impute missing covari-
ate information for women considered to be eligible for the
analysis (i.e., women who provided data on constipation
and LUTS). Missing information on all the confounders of
interest was therefore imputed. We generated 20 datasets
using multiple imputation by fully conditional specification
(chained equations). The imputation model included con-
stipation, all LUTS outcomes, and the confounders men-
tioned above. The main analysis results were obtained by
averaging across the results from each of these 20 datasets
using Rubin’s rules. All analyses were done using STATA/
MP 15 (StataCorp, TX).
Results
Table 1 compares the distribution of characteristics in the
complete-case and the multiple-imputed datasets for women
included in analyses. The distribution of background char-
acteristics was very similar before and after imputation. The
FIG. 1. Sample flowchart for con-
stipation and LUTS paper. *Any
LUTS includes storage symptoms
(stress UI, mixed UI, urgency UI, ur-
gency, nocturia, increased daytime
frequency) and voiding symptoms
(hesitancy and intermittency). LUTS,
lower urinary tract symptoms; UI,
urinary incontinence.

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 1. Distribution of Characteristics of Women Included in Analyses of Lower Urinary Tract
Symptoms in Complete Case, Observed and Imputed Datasets
Missing (n) Observed data Imputed data sets (%) n = 3,729
Age, mean (SE) 95 43.3 (0.08) 43.3 (0.01)
BMI, mean (SE) 369 24.3 (4.3) 24.3 (0.07)
Parity, n (%) 83
1 546 (15) 559 (15)
2 1,776 (49) 1,827 (49)
3+ 1,324 (36) 1,343 (36)
Hysterectomy, n (%) 95
Yes 122 (3) 112 (3)
No 3,512 (97) 3,617 (97)
Occupational social class, n (%) 372
Manual 564 (15) 634 (17)
Nonmanual 2,793 (85) 3,095 (83)
Physical activity (MET hours/week), n (%) 0
0 472 (13) 485 (13)
0.1–17.2 733 (20) 709 (19)
17.3–29.2 813 (22) 820 (22)
29.3–43.2 907 (24) 895 (24)
‡43.2 804 (21) 820 (22)
University degree, n (%) 310
Yes 261(8) 299 (8)
No 3,158 (92) 3,430 (92)
Constipation medication, n (%) 0
None 3,415 (92) 3,431(92)
Only one time point 227 (6) 224 (6)
Both time points 87 (2) 74 (2)
Constipation medication, n (%) 0
None 3,415 (92) 3,430 (92)
Any time point 314 (8) 299 (8)
Stress UI, n (%) 8
Yes 844 (23) 858 (23)
No 2,877 (77) 2,871 (77)
Urgency UI, n (%) 13
Yes 318 (9) 336 (9)
No 3,398 (91) 3,393 (91)
Mixed UI, n (%) 15
Yes 304 (9) 299 (8)
No 3,410 (91) 3,430 (92)
Increased daytime frequency, n (%) 7
Yes 531 (14) 552 (14)
No 3,191 (86) 3,207 (86)
Nocturia, n (%) 7
Yes 330 (9) 336 (9)
No 3,392 (91) 3,393 (91)
Urgency, n (%) 6
Yes 657 (18) 671 (18)
No 3,066 (82) 3,058 (82)
Any type of LUTS, n (%) 165
Yes 1,443 (40) 1,492 (40)
No 2,121 (60) 2,237 (60)
Hesitancy, n (%) 52
Yes 181 (6) 186 (5)
No 3,496 (94) 3,543 (95)
Intermittency, n (%) 15
Yes 341 (9) 336 (9)
No 3,373 (91) 3,393 (91)
BMI, body mass index; SE, standard error; LUTS, lower urinary tract symptoms; UI, urinary incontinence; MET, metabolic equivalents.
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most common type of LUTS was stress UI (23%). The
prevalence of any LUTS at 10 years of follow-up was 40%.
A total of 6% of women (n = 227) reported having used
medications for constipation at one of the time points, whereas
2% of women (n = 87) used medications for constipation at
both time points.
Table 2 shows women’s characteristics according to use of
medications for constipation. There was no strong evidence
for differences in the proportion of women in the different
constipation categories according to the confounders except
for hysterectomy.
Constipation and LUTS (by subtypes)
after 10 years of follow-up
Table 3 shows the associations between constipation and
risk of LUTS after 10 years of follow-up. Women who re-
ported taking medication for constipation at only one of the
points had an increased risk of urgency (adjusted RR = 1.35;
95% CI 1.04–1.95). The adjusted risk ratio for urgency in
women taking constipation medication at both time points
was larger (adjusted RR = 1.94; 95% CI 1.15–3.29), but CIs
overlapped. The risk of hesitancy was also increased in wo-
men taking medication for constipation at only one of the
time points (adjusted RR = 1.72; 95% CI 1.04–3.01) and both
time points (adjusted RR = 1.78; 95% CI 1.03–4.19). There
was no strong evidence of relationships between constipation
and any other LUTS subtypes. There was, however, some
evidence of a relationship between constipation and risk of
any type of LUTS (adjusted RR = 1.54; 95% CI 0.95–2.51) in
women reporting medication use for constipation at both time
points compared with the reference group, but not for women
who reported taking medication at only one time point.
Table 4 shows the findings of the analysis comparing
women who reported using medications for constipation at
any time point compared with women who reported not using
any medication for constipation at either time point. Overall,
the findings were similar to the main results. Women who
reported using constipation medication had increased risks of
urgency (adjusted OR = 1.51; 95% CI 1.10–2.05) and hesi-
tancy (adjusted OR = 1.88; 95% CI 1.16–3.04) compared
with women who did not use constipation medication. There
was no strong evidence of an association with other LUTS
subtypes. In line with the main analysis, there was some
evidence of a relationship between constipation and any type
of LUTS (adjusted RR = 1.18; 95% CI 0.91–1.55) in women
reporting taking medications for constipation at any time
point compared with neither.
Supplementary Tables S1 and S2 show the results of the
complete case analysis, which are similar to the main results.
Supplementary Tables S3 and S4 show the results of the
complete case analysis with updated confounders, which




We found evidence for an increased risk of LUTS after 10
years of follow-up among middle-aged parous women who
reported using medication for constipation compared with
women who did not use constipation medication. Specifi-
cally, women who used medications for constipation had an
increased risk of both urgency and hesitancy compared with
women who had not used medications for constipation.
Strengths and limitations
Strengths of our study include its prospective design, large
sample size, and use of a validated questionnaire to assess
LUTS. We were also able to investigate multiple subtypes of
LUTS. We adjusted for potentially important confounders,
Table 2. Characteristics of Women According to Use of Medication for Constipation by Confounders
Confounder
Constipation medication
None at both time
points (n = 3,415)
Only one time
point (n = 227)
Both time
points (n = 87) p-Value
Age, years [mean (SD)] 43.3 (0.5) 43.2 (0.5) 43.3 (0.5) 0.125
BMI (kg/m2) [mean (SD)] 24.3 (4.3) 24.8 (4.2) 24.1 (3.9) 0.262
Hysterectomy, % 0.005
Yes 3 4 0
Physical activity (MET hours/week), % 0.590
0 13 13 12
0.1–17.2 20 21 15
17.3–29.2 22 19 23
29.3–43.2 24 25 26
‡43.2 21 22 24
Occupational social class, % 0.559
Manual 17 14 17
Nonmanual 83 86 83
University degree, % 0.932
Yes 8 8 9
Parity, % 0.538
1 15 15 16
2 49 52 47
3+ 36 33 37
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including hysterectomy and physical activity at baseline. We
were also able to adjust for time updated measures of con-
founders. We used multiple imputation to minimize selection
bias due to missing information on potential confounders and
to increase statistical efficiency.
Although we had a large sample size, the number of par-
ticipants taking medication for constipation was relatively
small which resulted in wide CIs and, hence, a lack of pre-
cision in our results. We categorized constipation as ‘‘none,
yes at one of the two time points, and yes at both time points’’
and assumed that women who used medication at both time
points have the most severe (chronic) constipation. However,
these categories could include women who had mild con-
stipation (e.g., used a laxative once) to severe (e.g., used daily
laxatives). Physical activity is a behavior that may change
over the 10 years of follow-up, but we were unable to account
for changes in physical activity levels after baseline due to
a lack of data. Finally, all ALSPAC participants are parous
and predominantly white. The results might therefore not be
generalizable to nulliparous women or women of other ethnic
backgrounds.
Interpretation of our findings in light of other evidence
A single prospective study (n = 234 women recruited while
pregnant) has investigated the association between constipation
and UI. This study found that chronic constipation (women
scoring ‡9 using the Sandwell Incontinence Following Child-
birth Risk Assessment Tool risk scale) was associated with an
increased risk of stress UI 6 months after childbirth.22 In our
population of middle-aged women, we did not detect an asso-
ciation between constipation and stress UI.
Kaplan et al. conducted a systematic review of human and
animal studies examining the relationship between bowel
and bladder function and its implications for managing
coexisting constipation and overactive bladder symptoms
Table 3. Associations of Constipation with Lower Urinary Tract Symptoms
(by Subtype) at Ten Years of Follow-Up
Outcome Constipation medication N N cases (%) Unadjusted RR (95% CI) Adjusted RRa (95% CI)
Stress UI
None 3,409 762 (22) Ref Ref
Only one time point 225 56 (25) 1.15 (0.84–1.57) 1.17 (0.82–1.65)
Both time points 87 26 (30) 1.48 (0.92–2.36) 1.37 (0.80–2.31)
Increased daytime frequency
None 3,408 483 (14) Ref Ref
Only one time point 227 32 (14) 0.99 (0.68–1.46) 0.90 (0.58–1.40)
Both time points 87 16 (18) 1.36 (0.79–2.37) 1.46 (0.81–2.64)
Nocturia
None 3,408 302 (9) Ref Ref
Only one time point 227 17 (7) 0.83 (0.50–1.38) 0.68 (0.37–1.25)
Both time points 87 11 (13) 1.49 (0.79–2.83) 1.37 (0.65–2.91)
Urgency UI
None 3,404 288 (8) Ref Ref
Only one time point 225 22 (10) 1.17 (0.74–1.85) 0.99 (0.58–1.69)
Both time points 87 8 (9) 1.10 (0.52–2.29) 1.17 (0.53–2.60)
Urgency
None 3,411 584 (17) Ref Ref
Only one time point 225 51 (23) 1.42 (1.03–1.96) 1.35 (1.04–1.95)
Both time points 87 22 (25) 1.64 (1.00–2.68) 1.94 (1.15–3.29)
Mixed UI
None 3,402 274 (8) Ref Ref
Only one time point 225 21 (9) 1.18 (0.74–1.87) 1.07 (0.63–1.84)
Both time points 87 9 (10) 1.32 (0.65–2.66) 1.29 (0.58–2.87)
Hesitancy
None 3,369 155 (5) Ref Ref
Only one time point 222 17 (8) 1.72 (1.02–2.89) 1.72 (1.04–3.01)
Both time points 86 9 (10) 2.42 (1.19–4.92) 1.78 (1.03–4.19)
Intermittency
None 3,403 301 (9) Ref Ref
Only one time point 224 28 (13) 1.47 (0.97–2.22) 1.18 (0.72–1.94)
Both time points 87 12 (14) 1.65 (0.89–2.89) 1.49 (0.73–2.98)
Any type of LUTS
None 3,268 1,310 (40) Ref Ref
Only one time point 214 92 (43) 1.13 (0.85–1.49) 1.07 (0.78–1.46)
Both time points 82 41 (50) 1.49 (0.96–2.32) 1.54 (0.95–2.51)
aConfounders included for the adjusted models are age, parity, BMI, university degree and social status, physical activity and hysterectomy.
CI, confidence interval; RR, relative risk.
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(OAB), including urgency UI, nocturia, frequency and ur-
gency8 and concluded that bowel distension affects bladder
activity and that constipation can contribute in the devel-
opment of OAB symptoms, especially frequency and ur-
gency. This in line with our findings indicating a positive
association between constipation and urgency.
Additional support for a causal effect of constipation on
LUTS comes from an intervention study examined the effect of
alleviating constipation on LUTS, including urgency and fre-
quency. Fifty-two older participants (42 men and 10 women;
ages 65–89) with chronic constipation and LUTS self-reported
constipation and LUTS by filling in a questionnaire at study
enrolment and during monthly visits. The study reported that
treating constipation decreased urgency and urinary frequency.23
Although, studies mentioned above have reported an in-
creased risk of stress UI and increased daytime frequency in
constipated patients,22,23 our results suggested a 40% increased
risk of increased daytime frequency and stress UI; however, CIs
were wide and crossed the null value. This is probably due to
limited power as a consequence of the modest number of wo-
men who were using constipation medication at baseline.
Possible mechanisms explaining the association
between constipation and LUTS
Constipation left untreated over a long period of time could
cause changes in the pelvic floor through several mechanisms,
which may result in an increased risk of developing LUTS.
Anatomically, the rectum and the bladder are aligned close
to each other and therefore share the muscular structure of
the pelvic floor. Over time, the cumulative effect of con-
stipation on pelvic floor musculature, may result in high
muscle tone, which could cause dysfunctional elimination
of urine.8,9 Constipation could also cause women to strain
while emptying the bowel which could put pressure on the
pelvic floor muscles. Continuous straining due to constipa-
tion over time could cause weakness in pelvic floor muscles
resulting in pelvic organ prolapse, which could increase risk
of developing LUTS.8,9
The overlapping and convergence of the lower urinary
tract and lower bowel innervation can lead to two-way in-
teractions in afferent activity between the two structures.
Accordingly, we speculate that the increased afferent activity
due to the abnormal presence of feces in the bowel collater-
ally sensitizes the urinary tract afferents, so the sensory return
is disproportionately high for the volume in the bladder. This
might also explain the association with hesitancy, since the
increased sensation may cause the affected person to visit the
toilet when their bladder is underfilled.
Conclusion
To date, there have been limited prospective studies con-
cerning the association between constipation and LUTS. We
Table 4. Associations of Constipation and Lower Urinary Tract Symptoms
(by Subtype) at Ten Years of Follow-Up
Outcome Constipation medication N N cases (%) Unadjusted RR (95% CI) Adjusted RRa (95% CI)
Stress incontinence
None 3,409 76 (22) Ref Ref
Any time point 312 82 (26) 1.24 (0.95–1.61) 1.22 (0.91–1.64)
Frequency
None 3,408 483 (14) Ref Ref
Any time point 314 48 (15) 1.09 (0.80–1.51) 1.05 (073–1.50)
Nocturia
None 3,408 302 (9) Ref Ref
Any time point 314 28 (9) 1.00 (0.80–1.51) 0.85 (0.53–1.38)
Urgency incontinence
None 3,404 288 (8) Ref Ref
Any time point 312 30 (10) 1.15 (0.78–1.71) 1.04 (0.66–1.63)
Urgency
None 3,411 584 (17) Ref Ref
Any time point 312 73 (23) 1.48 (1.12–1.95) 1.51 (1.10–2.05)
Mixed incontinence
None 3,402 274 (8) Ref Ref
Any time point 312 30 (10) 1.21 (0.78–1.71) 1.13 (0.72–1.28)
Hesitancy
None 3,369 155 (5) Ref Ref
Any time point 308 26 (8) 1.91 (1.24–2.94) 1.88 (1.16–3.04)
Intermittency
None 3,403 301 (9) Ref Ref
Any time point 311 40 (13) 1.52 (1.07–2.16) 1.26 (0.83–1.91)
Any type of LUTS
None 3,268 1,310 (40) Ref Ref
Any time point 296 133 (45) 1.22 (0.95–1.61) 1.18 (0.91–1.55)
aConfounders included for the adjusted models are age, parity, BMI, university degree and social status, physical activity and
hysterectomy.
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found that constipation was prospectively associated with
increased risks of urgency and hesitancy among parous
middle-aged women. This study potentially highlights that
untreated constipation could result in risk of developing LUTS
in parous middle-aged women. If further research finds evi-
dence that this association is causal, this implies that women
should seek treatment to alleviate constipation to reduce their
consequent risk of developing these LUTS.
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